BROOKLYN IMMUNOTHERAPEUTICS's ticker is BTX and the CUSIP is 114082100. A total of 62 filers reported holding BROOKLYN IMMUNOTHERAPEUTICS in Q1 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $0 | -100.0% | 1,427 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | -66.7% | 1,427 | 0.0% | 0.00% | – |
| Q1 2022 | $3,000 | -50.0% | 1,427 | 0.0% | 0.00% | – |
| Q4 2021 | $6,000 | -53.8% | 1,427 | 0.0% | 0.00% | -100.0% |
| Q3 2021 | $13,000 | -50.0% | 1,427 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $26,000 | – | 1,427 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|